JPMorgan Chase & Co. Buys 271,295 Shares of Genpact Limited (NYSE:G)

JPMorgan Chase & Co. lifted its position in shares of Genpact Limited (NYSE:GFree Report) by 8.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,400,636 shares of the business services provider’s stock after purchasing an additional 271,295 shares during the quarter. JPMorgan Chase & Co. owned about 1.93% of Genpact worth $146,057,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. CIBC Asset Management Inc raised its holdings in Genpact by 5.5% in the 4th quarter. CIBC Asset Management Inc now owns 5,692 shares of the business services provider’s stock worth $244,000 after acquiring an additional 297 shares during the last quarter. Tealwood Asset Management Inc. raised its stake in shares of Genpact by 1.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 24,658 shares of the business services provider’s stock worth $1,059,000 after purchasing an additional 339 shares during the last quarter. UMB Bank n.a. lifted its holdings in shares of Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after purchasing an additional 433 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Genpact by 8.7% during the fourth quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider’s stock valued at $217,000 after buying an additional 441 shares during the last quarter. Finally, J.Safra Asset Management Corp increased its holdings in Genpact by 38.8% in the 4th quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider’s stock worth $69,000 after buying an additional 453 shares in the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.

Genpact Price Performance

NYSE G opened at $50.59 on Wednesday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The business’s fifty day moving average is $51.03 and its 200 day moving average is $45.27. The company has a market capitalization of $8.89 billion, a PE ratio of 17.81, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $56.76.

Genpact (NYSE:GGet Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Sell-side analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were issued a $0.17 dividend. The ex-dividend date of this dividend was Tuesday, March 11th. This represents a $0.68 annualized dividend and a yield of 1.34%. This is an increase from Genpact’s previous quarterly dividend of $0.15. Genpact’s dividend payout ratio is currently 23.94%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on G shares. Mizuho raised their price target on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Needham & Company LLC lifted their target price on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and boosted their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and raised their price target for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $48.44.

Check Out Our Latest Report on Genpact

Insiders Place Their Bets

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by company insiders.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.